Actinobac Biomed, Inc.
Actinobac Biomed, Inc. is a biopharmaceutical company that focuses on the development of pharmaceutical technologies based upon the natural biologic agent leukotoxin (Leukothera™), which targets Leukocyte Function Antigen-1 (LFA-1) on white blood cells.
Categories
Industry | Biomedical |
Sub-industry | |
Focus Areas | |
Focus Areas - detailed |
University
University | Rutgers |
Principal Investigator | Scott Kachlany, Ph.D. - Center for Oral Infectious Diseases, School of Dental Medicine |
Company
Web | http://actinobac.com/ |
Address | |
Phone | |
Fax | |
Timeline
2009 - Founded
No files attached to this page.